Establishment, characterization and drug sensitivity testing in primary cultures of human thymoma and thymic carcinoma
Open Access
- 9 April 2008
- journal article
- research article
- Published by Wiley in International Journal of Cancer
- Vol. 122 (12) , 2719-2725
- https://doi.org/10.1002/ijc.23335
Abstract
Thymomas and thymic carcinomas are peculiar epithelial tumors of the anterior mediastinum. They may show aggressive clinical behavior and are a paradigm for the interaction between the tumor and the immune system. So far, adequate functional studies enabling a better understanding of this malignancy have not been performed, since human thymoma/thymic carcinoma cell lines have not been available. Here, the authors describe the establishment, characterization and functional analyses of epithelial cell lines from a Type B1‐thymoma and a poorly differentiated thymic carcinoma. By Fluorescence‐activated cell sorting (FACS) analyses, both cell lines were aneuploid. The aneuploid cell fraction of the thymic carcinoma cell line was characterized by a high proliferation index of 55.9%, in contrast to a lower proliferation rate of the aneuploid cell fraction of the thymoma (19.7%). Array‐based comparative genomic hybridization (aCGH) and conventional cytogenetic analysis of the thymoma revealed only minor imbalances whereas the thymic carcinoma was characterized by a complex karyotype in the hyperdiploid range that was readily defined with multicolor FISH (mFISH). Application of a selective COX‐2 inhibitor reduced cell viability in both cell lines in a dose‐dependent manner. In conclusion, these first cell lines of a thymoma and a CD5‐positive thymic carcinoma are useful tools for further in vitro studies of cellular, molecular and genetic aspects of the disease and for functional tests to evaluate new therapeutic targets.Keywords
This publication has 19 references indexed in Scilit:
- COX‐2 upregulation in thymomas and thymic carcinomasInternational Journal of Cancer, 2006
- Thymoma and Thymic Carcinoma: An Update of the WHO Classification 2004Surgery Today, 2005
- Treatment of malignant thymomaCurrent Opinion in Oncology, 2005
- Thymic Carcinoma with Overexpression of MutatedKITand the Response to ImatinibNew England Journal of Medicine, 2004
- DNA microarrays for comparative genomic hybridization based on DOP‐PCR amplification of BAC and PAC clonesGenes, Chromosomes and Cancer, 2003
- New WHO histologic classification predicts prognosis of thymic epithelial tumorsCancer, 2002
- Histologic classification of thymic epithelial tumors: Comparison of established classification schemesInternational Journal of Cancer, 2002
- Recurrent Genetic Aberrations in Thymoma and Thymic CarcinomaThe American Journal of Pathology, 2000
- Matrix-based comparative genomic hybridization: Biochips to screen for genomic imbalancesGenes, Chromosomes and Cancer, 1997
- Follow-up study of thymomas with special reference to their clinical stagesCancer, 1981